Global Orthobiologics Market to Grow with a CAGR of 5.10% through 2030F
Rising prevalence of
road accidents are expected to drive the Global Orthobiologics Market in the
forecast period 2026-2030F
According to TechSci
Research report, “Global Orthobiologics Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global Orthobiologics Market stood at USD 5.89 billion in 2024 and is
anticipated to grow with a CAGR of 5.10% in the forecast period, 2026-2030F.
The significant growth drivers of the orthobiologics market include a rising
incidence of sports injuries, road accidents, osteoarthritis, and an increasing
preference for minimally invasive surgical approaches.
The global increase in
the aging population and the prevalence of obesity are contributing to a higher
incidence of osteoarthritis and musculoskeletal disorders. The World Health
Organization reported that in 2021, around 1.71 billion people worldwide had
musculoskeletal conditions. Low back pain, in particular, had the highest
prevalence, affecting 568 million individuals. In the United Kingdom, more than
20 million people, approximately one-third of the population, live with
musculoskeletal conditions such as arthritis and low back pain. These
conditions significantly impact the quality of life and contribute to the
burden of illness and disability. With the growing number of musculoskeletal
injuries, there is a corresponding rise in demand for orthobiologics, which is
expected to fuel market growth. The introduction of new orthobiologic products
and strategic initiatives by key market players is anticipated to further boost
market expansion. For instance, Ventris Medical launched Allocell AF in April
2021, a next generation osteoinductive fiber allograft designed to enhance
intra-operative handling and improve biological responsiveness at the site of
injury. However, the high cost associated with biologic-based treatments and
the preference for alternative therapies pose potential hindrances to market growth.
Orthobiologics refer to
a category of biological substances or materials that are used to promote the
healing, regeneration, or replacement of musculoskeletal tissues, such as
bones, cartilage, tendons, and ligaments. These materials are derived from natural
sources or can be produced synthetically and are utilized in orthopedic and
musculoskeletal medicine to treat a range of conditions and injuries. Here are
some key applications of orthobiologics: Bone Grafting: Orthobiologics are
often employed in bone grafting procedures to stimulate bone growth and repair.
Autologous bone grafts (taken from the patient's own body), allografts (from
donors), or synthetic bone substitutes can be augmented with orthobiologics
like growth factors, stem cells, or bone morphogenetic proteins (BMPs) to
enhance the fusion and healing of fractured or damaged bones. Cartilage Repair:
Orthobiologics play a crucial role in the treatment of cartilage injuries and
degenerative conditions like osteoarthritis. They can be used in conjunction
with procedures like microfracture, autologous chondrocyte implantation (ACI),
or osteochondral grafting to stimulate cartilage regeneration and reduce pain.
Tendon and Ligament Repair: Orthobiologics, particularly platelet-rich plasma
(PRP), are applied in the management of tendon and ligament injuries. PRP
injections can promote tissue healing, reduce inflammation, and enhance the
recovery of structures like the Achilles tendon or anterior cruciate ligament
(ACL). Spinal Fusion: Orthobiologics are frequently utilized in spinal fusion
surgeries to stimulate bone growth and facilitate the fusion of vertebrae.
BMPs, in particular, have been approved for this application, reducing the need
for traditional bone grafts. Soft Tissue Repair: Injuries to soft tissues like
tendons and ligaments can benefit from orthobiologic treatments. These
substances can enhance the healing process, reduce pain, and improve function
following injuries.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "Global Orthobiologics Market”
The Global
Orthobiologics Market is driven by several key factors:
Increasing Incidence of
Musculoskeletal Conditions: The growing prevalence of musculoskeletal disorders
such as osteoarthritis, osteoporosis, and sports-related injuries is a
significant driver. As the global population ages and lifestyles become more sedentary,
the demand for orthobiologic treatments to alleviate pain and restore function
is on the rise. Preference for Minimally Invasive Procedures: Patients and
healthcare providers are increasingly favoring minimally invasive orthopedic
procedures over traditional open surgeries. Orthobiologics, which can be
administered via injections or arthroscopic techniques, align with this trend,
offering reduced recovery times, shorter hospital stays, and less
post-operative pain. Advancements in Biotechnology: Continuous advancements in
biotechnology have led to the development of more sophisticated orthobiologic
products. These innovations include the isolation of growth factors, stem cell
therapies, and tissue engineering techniques that enhance the effectiveness of
regenerative treatments. Sports-Related Injuries: The rise in sports
participation and athletic activities has led to a higher incidence of
sports-related injuries, including ligament tears and cartilage damage.
Orthobiologics, especially when combined with minimally invasive procedures,
are increasingly used to treat athletes and active individuals, driving market
growth. Rising Geriatric Population: The aging global population is at a higher
risk of musculoskeletal conditions, including osteoarthritis and
fractures.
The Global
Orthobiologics Market is segmented into product, application, end user,
regional distribution, and company.
Based on product, Viscosupplementation
Products dominate the global orthobiologics market. This is primarily due to
their widespread use in managing osteoarthritis, particularly knee
osteoarthritis, which affects millions globally. Viscosupplementation involves
injecting hyaluronic acid into the joint to improve lubrication, reduce pain,
and enhance mobility. Its minimally invasive nature, quick recovery time, and
ability to delay or reduce the need for joint replacement surgeries make it a
preferred treatment option. The growing aging population and increasing incidence
of joint disorders further drive demand. The ongoing improvements in hyaluronic
acid formulations and delivery methods have enhanced product efficacy and
patient outcomes. These factors collectively contribute to the strong market
position and continued growth of viscosupplementation products within the
orthobiologics landscape.
Based on region, the
market is segmented into North America, Europe, Asia Pacific, Central &
South America, Middle East & Africa. Asia-Pacific is the
fastest-growing region in the global orthobiologics market due to several key
factors. Rapidly aging populations in countries like Japan and China are
leading to a surge in musculoskeletal disorders, including osteoarthritis and
spinal conditions. The rising healthcare awareness and increased access to
advanced medical treatments are boosting demand for orthobiologic therapies.
Governments across the region are investing heavily in healthcare
infrastructure, while medical tourism is flourishing due to lower treatment
costs and improving quality of care. The growing adoption of minimally invasive
procedures, expanding orthopedic research, and an increasing number of trained
specialists are fueling market growth. These combined factors make Asia-Pacific
a hotspot for innovation and expansion in the orthobiologics sector.
Major companies
operating in Global Orthobiologics Market are:
·
Sanofi SA
·
Stryker Corporation
·
Zimmer Biomet
·
Seaspine Holdings
Corporation
·
Medtronic PLC
·
DePuy Synthes
·
Bioventrus
·
Globus Medical
·
Arthrex Limited
·
Orthofix International
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“The Global
Orthobiologics Market is driven by several compelling factors that collectively
contribute to its rapid growth and innovation in the healthcare industry. The
growing prevalence of musculoskeletal disorders such as osteoarthritis,
osteoporosis, and sports-related injuries is a significant driver. As the
global population ages and lifestyles become more sedentary, the demand for
orthobiologic treatments to alleviate pain and restore function is on the rise,
propell the growth of Global Orthobiologics Market. The rise in sports
participation and athletic activities has led to a higher incidence of
sports-related injuries, including ligament tears and cartilage damage.
Orthobiologics, especially when combined with minimally invasive procedures,
are increasingly used to treat athletes and active individuals, driving market
growth contributes to foster the demand for Global Orthobiologics Market in the
forecast period” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Orthobiologics Market, By Product
(Viscosupplementation Products, Demineralized Bone Matrices, Synthetic
Orthobiologics, Bone Morphogenic Protein, Allografts, and Others), By
Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion,
Soft-tissue Injuries, and Others), By End User (Hospitals, Orthopedic Clinics,
and Ambulatory Care Centers, Academic and Research Institutes, and Dental
Clinics and Facilities), By Region & Competition 2020-2030F” has evaluated the future growth potential of Global
Orthobiologics Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Orthobiologics
Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com